Skip to content

Chronic Pain Skills Study - Vanderbilt University Medical Center

CompletedNot applicableNCT03384953
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The Osher Center for Integrative Medicine (OCIM) at Vanderbilt is a multidisciplinary outpatient clinic treating patients with chronic pain and complex health issues via integrative services, with goals of improving overall health and wellbeing of those served. At OCIM, clinical hypnosis has been historically provided on an individual basis by the investigator. Due to its impact and increased patient demand for this service, the investigator will be conducting group hypnosis services in addition to individual services order to expand the reach of this program to participants. As such, the investigators see this as a tremendous opportunity to contribute to clinical research to contribute to the evidence based for this form of service by examining participant-reported outcomes associated with completing the treatment. For this project, the investigators seek to assess the impact of a manualized group treatment protocol utilizing clinical hypnosis as a treatment for chronic pain. The investigators will be evaluating participant-reported outcomes to assess the feasibility of conducting hypnosis in this setting, impact of group hypnosis on pain and how participants' responsiveness to hypnosis impacts treatment outcome.

Study details

Official title
Chronic Pain Skills Study - Vanderbilt University Medical Center
Conditions
Interventions
  • Behavioral: Clinical Hypnosis - Group Treatment
  • Behavioral: Clinical Hypnosis - Individual Treatment
Sponsor
Vanderbilt University Medical Center
Start date
2017-06-22
Primary completion
2020-02-13
Sex
All
Age range
from 18 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. 18 years of age or older; \* 2. Self-reported presence of chronic pain;\*\* 3. Average pain intensity rating of ≥ 3 on a 0-10 Numerical Rating Scale (NRS) of pain intensity in the last week; \*\* 4. Worst pain intensity rating of ≥ 5 on a 0-10 Numerical Rating Scale (NRS) of pain intensity in the last week;\*\* 5. Duration of chronic pain 3 months or more; \*\* 6. Experiences pain at least 75% of the time in the past 3 months; Those who have a hard time answering this question will be asked the following question: "Which statement best describes your pain?" 1. Pain all the time, but the pain intensity varies; 2. Pain most of the time with only occasional periods of being pain-free; 3. Pain that comes and goes; 4. Occasional pain; Participants must report experiencing pain that matches one of the first two options;\*\* 7. Able to read, speak, and understand English.\*\* Exclusion Criteria: 1. Cognitive impairment or limitations (i.e. history of moderate to severe Traumatic Brain Injury (TBI), unresolved TBI, or other medical condition) that would interfere with a patient's ability to participate in a group involving focused attention\*. 2. Current or history of diagnosis of primary psychotic or major thought disorder as listed in participant's medical record or self-reported within the past five years;\* 3. Hospitalization for psychiatric reasons other than suicidal ideation, homicidal ideation, and/or PTSD self-reported or noted in chart (within the past 5 years);\* 4. Psychiatric or behavioral conditions in which symptoms are unstable or severe (e.g. current delirium, mania, psychosis, suicidal ideation, homicidal ideation, substance abuse dependency) as listed in participant's medical record or self-reported within the past six months;\* 5. Any behavioral issues as noted in the medical record or by a provider that would indicate the participant may be inappropriate in a group setting;\*\*\* 6. Presenting symptoms at time of screening that would interfere with participation, specifically active suicidal ideation with intent to harm oneself or active delusional or psychotic thinking;\*\* 7. Difficulties or limitations communicating over the telephone;\*\* 8. Any planned life events that would interfere with participating in the key elements of the study.\*\* 9. Reported average daily use of \>120mg morphine equivalent dose (MED). \*\* * also verified via medical record review, as described below. \*\*verified solely via self-report, …

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03384953